Physician profile
Peter J Kemp
NPI 1063404184
$1,820.46
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $155 · 2021: $442 · 2022: $545 · 2023: $236 · 2024: $43.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $473.33 | 2019-2022 | |
| Daiichi Sankyo INC. | $347.66 | 2019-2022 | |
| Myovant Sciences INC. | $114.16 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $102.90 | 2023 | Myrisk |
| Scynexis, INC. | $96.63 | 2022 | |
| Avion Pharmaceuticals | $77.59 | 2021-2022 | |
| Coopersurgical, INC. | $69.55 | 2019 | |
| Exeltis, USA INC. | $69.05 | 2021-2023 | Slynd |
| Astellas Pharma US INC | $49.75 | 2023 | Veozah |
| Merck Sharp & Dohme LLC | $44.87 | 2019-2021 | |
| Mimedx Group, INC. | $43.61 | 2024 | |
| Karl Storz Endoscopy-America | $43.38 | 2022 | |
| Sumitomo Pharma America, INC. | $41.35 | 2023 | Myfembree |
| Organon LLC | $33.91 | 2021-2022 | |
| Pfizer INC. | $31.31 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $27.85 | 2020-2022 | |
| Pharmacosmos Therapeutics INC. | $26.90 | 2023 | Monoferric |
| Alydia Health | $26.62 | 2021 | |
| Portola Pharmaceuticals, LLC | $21.54 | 2019 | |
| Hologic Sales and Service, LLC | $20.69 | 2019 | |
| Lupin INC. | $18.14 | 2019 | |
| Smith+Nephew, INC. | $15.41 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $12.20 | 2022 | |
| Intuitive Surgical, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Kemp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.